(i)
CEO Employee Email
From: Amir Rubin
Date: Thu, Jul 21, 2022 at 5:36 AM
Subject: One Medical to be
acquired by Amazon...
Dear Colleagues,
We are delighted
to share that weve signed an agreement to be acquired by Amazon! This exciting opportunity will further support us in our mission to transform healthcare for all through our human-centered, technology-powered model. Joining Amazon is a
tremendous next step in our journey to deliver better health, better care, better value, in a better team environment.
Please join a special Town Huddle
to learn more about this exciting news. We will share Zoom meeting details via a calendar invitation shortly. With this announcement, you may receive questions, so please refer to our OneSource page for additional resources, or the press
release. We will share further updates as we proceed ahead.
Thank you for all you do every day, as in the meantime we continue on our mission and
objectives on all fronts!
Sincerely,
Amir
Additional Information and Where to Find It
In
connection with the proposed acquisition of One Medical by Amazon, One Medical intends to file with the SEC preliminary and definitive proxy statements relating to such acquisition and other relevant documents. The definitive proxy statement
will be mailed to One Medicals stockholders as of a record date to be established for voting on the proposed acquisition and any other matters to be voted on at the special meeting. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND
SECURITY HOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENTS, ANY AMENDMENTS OR SUPPLEMENTS THERETO, ANY OTHER SOLICITING MATERIALS AND ANY OTHER DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED ACQUISITION OR INCORPORATED BY
REFERENCE IN THE PROXY STATEMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ONE MEDICAL AND THE PROPOSED ACQUISITION. Investors and security holders may obtain free copies of these documents (when they are
available) on the SECs web site at www.sec.gov, on One Medicals website at https://investor.onemedical.com/ or by contacting One Medicals Investor Relations via email at
https://investor.onemedical.com/contact-ir.
Participants in the Solicitation
One Medical and its directors and executive officers may be deemed participants in the solicitation of proxies from the stockholders of One Medical in
connection with the proposed acquisition and any other matters to be voted on at the special meeting. Information regarding the names, affiliations and interests of such directors and executive officers will be included in the preliminary and
definitive proxy statements (when available). Additional information regarding such directors and executive officers is included in One Medicals definitive proxy statement on Schedule 14A for the 2022 Annual Meeting of Stockholders, which was
filed with the SEC on April 21, 2022.
Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of
proxies of One Medicals stockholders in connection with the proposed acquisition and any other matters to be voted upon at the special meeting will be set forth in the preliminary and definitive proxy statements (when available) for the
proposed acquisition. These documents are available free of charge as described in the preceding paragraph.
(i)